Spital Square Limited 03298997 false 2023-04-06 2024-04-05 2024-04-05 The principal activity of the company is property investment. Digita Accounts Production Advanced 6.30.9574.0 true 03298997 2023-04-06 2024-04-05 03298997 2024-04-05 03298997 bus:OrdinaryShareClass1 2024-04-05 03298997 core:RetainedEarningsAccumulatedLosses 2024-04-05 03298997 core:ShareCapital 2024-04-05 03298997 core:CurrentFinancialInstruments 2024-04-05 03298997 core:CurrentFinancialInstruments core:WithinOneYear 2024-04-05 03298997 core:Non-currentFinancialInstruments 2024-04-05 03298997 core:Non-currentFinancialInstruments core:AfterOneYear 2024-04-05 03298997 bus:SmallEntities 2023-04-06 2024-04-05 03298997 bus:AuditExemptWithAccountantsReport 2023-04-06 2024-04-05 03298997 bus:FilletedAccounts 2023-04-06 2024-04-05 03298997 bus:SmallCompaniesRegimeForAccounts 2023-04-06 2024-04-05 03298997 bus:RegisteredOffice 2023-04-06 2024-04-05 03298997 bus:CompanySecretary1 2023-04-06 2024-04-05 03298997 bus:Director1 2023-04-06 2024-04-05 03298997 bus:Director2 2023-04-06 2024-04-05 03298997 bus:OrdinaryShareClass1 2023-04-06 2024-04-05 03298997 bus:PrivateLimitedCompanyLtd 2023-04-06 2024-04-05 03298997 bus:Agent1 2023-04-06 2024-04-05 03298997 core:InvestmentPropertyIncludedWithinPPE 2023-04-06 2024-04-05 03298997 countries:EnglandWales 2023-04-06 2024-04-05 03298997 2023-04-05 03298997 2022-04-06 2023-04-05 03298997 2023-04-05 03298997 bus:OrdinaryShareClass1 2023-04-05 03298997 core:RetainedEarningsAccumulatedLosses 2023-04-05 03298997 core:ShareCapital 2023-04-05 03298997 core:CurrentFinancialInstruments 2023-04-05 03298997 core:CurrentFinancialInstruments core:WithinOneYear 2023-04-05 03298997 core:Non-currentFinancialInstruments 2023-04-05 03298997 core:Non-currentFinancialInstruments core:AfterOneYear 2023-04-05 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 03298997

Spital Square Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 5 April 2024

 

Spital Square Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 8

 

Spital Square Limited

Company Information

Directors

Mr C R W Parish

Mr S J J Wedgwood

Company secretary

Mr P N Wilson

Registered office

18 Princelet Street
London
E1 6QH

Bankers

Handelsbanken
Moorgate
4 Moorgate
London
EC2R 6DA

Accountants

Young & Co
Chartered Accountants
St Ethelbert House
Ryelands Street
Hereford
Herefordshire
HR4 0LA

 

Spital Square Limited

(Registration number: 03298997)
Balance Sheet as at 5 April 2024

Note

2024
£

2023
£

Fixed assets

 

Investment property

4

2,500,000

2,500,000

Current assets

 

Debtors

5

4,947

-

Cash at bank and in hand

 

60,069

73,573

 

65,016

73,573

Creditors: Amounts falling due within one year

6

(131,405)

(117,218)

Net current liabilities

 

(66,389)

(43,645)

Total assets less current liabilities

 

2,433,611

2,456,355

Creditors: Amounts falling due after more than one year

6

(525,000)

(525,000)

Provisions for liabilities

(354,697)

(346,631)

Net assets

 

1,553,914

1,584,724

Capital and reserves

 

Called up share capital

7

5

5

Retained earnings

1,553,909

1,584,719

Shareholders' funds

 

1,553,914

1,584,724

For the financial year ending 5 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Spital Square Limited

(Registration number: 03298997)
Balance Sheet as at 5 April 2024
(continued)

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 31 July 2024 and signed on its behalf by:
 

.........................................
Mr S J J Wedgwood
Director

 

Spital Square Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
18 Princelet Street
London
E1 6QH
England

These financial statements were authorised for issue by the Board on 31 July 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Spital Square Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2024
(continued)

2

Accounting policies (continued)

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Depreciation

Asset class

Depreciation method and rate

Investment property

None

Investment property

Investment property is carried at fair value, derived from the current market prices for comparable real estate determined annually by external valuers. The valuers use observable market prices, adjusted if necessary for any difference in the nature, location or condition of the specific asset. Changes in fair value are recognised in profit or loss.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Spital Square Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2024
(continued)

2

Accounting policies (continued)

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).

4

Investment properties

2024
£

At 6 April

2,500,000

At 5 April

2,500,000

Investment property is valued on an open market basis.

There has been no valuation of investment property by an independent valuer.

5

Debtors

Current

2024
£

2023
£

Trade debtors

4,947

-

 

4,947

-

 

Spital Square Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2024
(continued)

6

Creditors

Creditors: amounts falling due within one year

2024
£

2023
£

Due within one year

Taxation and social security

14,865

-

Accruals and deferred income

116,540

117,218

131,405

117,218

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

9

525,000

525,000

7

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary shares of £1 each

5

5

5

5

       

8

Reserves

Deferred tax is provided on movements in the fair value reserve. The deferred tax charge or credit is included in the movement in the fair value reserve for the year.

 

Spital Square Limited

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2024
(continued)

9

Loans and borrowings

Non-current loans and borrowings

2024
£

2023
£

Other borrowings

525,000

525,000

Other borrowings

Shareholder loans with a carrying amount of £Nil (2023 - £525,000) are denominated in £ with a nominal interest rate of 12.93%.

The loans are unsecured.